Café

© 2026 Longbridge｜Terms of Service Privacy Policy

Incyte

INCY

132.05011.09% ( +13.180 )

Trading: Jul 28, 15:40:29 (EDT)

OverviewOverview OptionsOptions NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

James Michael Morrissey Expands Holdings With $54K Incyte Stock Options Acquisition
benzinga_article·4 hours ago
INCY+11.09%
ServiceNow, Meta, eBay And A Health Care Stock On CNBC’s ‘Final Trades’
benzinga_article·7 hours ago
NOW+4.06%INCY+11.09%
INCY: Q2 2026 revenue grew 38% year-over-year, driven by strong sales and a one-time Opzelura benefit
Quartr·8 hours ago
INCY+11.09%
Incyte | 8-K: FY2026 Q2 Revenue Beats Estimate at USD 1.674 B
Earnings Watch·8 hours ago
INCY+11.09%
Incyte Corp. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains
MarketWatch Automated·22 hours ago
INCY+11.09%
What To Expect From Incyte’s (INCY) Q2 Earnings
Stock Story·1 day ago, 10:04 PM
INCY+11.09%
Incyte Corp. Stock Outperforms Competitors Despite Losses On The Day
MarketWatch Automated·Jul 22 at 04:02 PM
INCY+11.09%
Incyte Corp. Stock Outperforms Competitors On Strong Trading Day
MarketWatch Automated·Jul 21 at 04:03 PM
INCY+11.09%
Halozyme and Incyte sign licence agreement for INCA033989 formulations
Pharmaceutical Business Review·Jul 21 at 04:15 AM
INCY+11.09%HALO+3.36%